Skip to main content
Retour
Watch Compare

PURE BIOSCIENCE, INC.

Qualité des données : 100%
PURE
OTC Manufacturing Chemicals
0,08 €
0,00 € (0,00%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-12,20%

Croissance

Revenue Growth (5Y)
-12,20%
En dessous de la moyenne du secteur (1,72%)
Revenue (1Y)12,43%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-89,97%
Op. Margin-82,51%

Sécurité

Debt / Equity
N/A
Current Ratio0,25
Interest Coverage-5,74

Valorisation

PE (TTM)
-4,40
En dessous de la moyenne du secteur (-1,50)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue declined -12,20% annually over 5 years
Negative free cash flow of -1,82 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 24,63%

Price History

Tendances Financières

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Surprises de Résultats

EPS
Reported Estimate
Q32017 Q42017 Q12018 Q22018
Reported -0,02 € -0,04 € -0,03 € -0,02 €
Estimate -0,03 € -0,02 € -0,02 € -0,02 €
Surprise +23,33% -100,00% -50,00% 0,00%

Growth

Rev 5Y: -12,20% · Earnings 1Y: N/A
Revenue Growth (1Y) 12,43% Revenue Growth (3Y) 8,39%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -12,20% Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: -89,97%
Revenue (TTM) 2,40 M Net Income (TTM) -2,16 M
ROE N/A ROA -218,95%
Gross Margin 59,91% Operating Margin -82,51%
Net Margin -89,97% Free Cash Flow (TTM) -1,82 M
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0,25
Debt / Equity N/A Current Ratio 0,25
Interest Coverage -5,74 Asset Turnover 2,43
Working Capital -2,28 M Tangible Book Value -6,27 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -4,40 · EV/EBITDA: N/A
P/E Ratio -4,40 Forward P/E N/A
P/B Ratio N/A P/S Ratio 3,96
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -19,18%
Market Cap 9,51 M Enterprise Value 9,31 M

Per Share

EPS: -0,02 · FCF/Share: -0,02
EPS (Diluted TTM) -0,02 Revenue / Share 0,02
FCF / Share -0,02 OCF / Share -0,02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 84,41% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 84,41%
SBC-Adj. FCF -2,01 M Growth Momentum 24,63

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2,20 M 1,96 M 1,87 M 1,81 M 3,70 M
Net Income -2,40 M -3,35 M -3,96 M -3,49 M -2,32 M
EPS (Diluted) -0,02 -0,03 -0,04 — -0,03
Gross Profit 1,30 M 1,15 M 971 000,0 1,00 M 2,08 M
Operating Income -2,27 M -3,19 M -3,94 M -3,72 M -2,31 M
EBITDA — — — — —
R&D Expenses 316 000,0 302 000,0 297 000,0 319 000,0 339 000,0
SG&A Expenses 3,26 M 3,98 M 4,30 M 4,11 M 4,05 M
D&A 2 000,0 148 000,0 117 000,0 213 000,0 172 000,0
Interest Expense 287 000,0 155 000,0 14 000,0 6 000,0 4 000,0
Income Tax 0,0 0,0 1 650,0 1 650,0 1 650,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,06 M 818 000,0 1,83 M 4,48 M 4,30 M
Total Liabilities 6,17 M 3,68 M 1,55 M 575 000,0 970 000,0
Shareholders' Equity -5,12 M -2,86 M 272 000,0 3,91 M 3,33 M
Total Debt — — — — —
Cash & Equivalents 334 000,0 349 000,0 1,10 M 3,39 M 2,39 M
Current Assets 1,05 M 805 000,0 1,60 M 3,86 M 3,20 M
Current Liabilities 938 000,0 733 000,0 532 000,0 575 000,0 970 000,0

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -4,4 -1,5
P/B — 1,6
ROE % — -54,7
Net Margin % -90,0 -41,5
Rev Growth 5Y % -12,2 1,7
D/E — 0,3